We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$175M
2
WELL icon
Welltower
WELL
+$148M
3
CUZ icon
Cousins Properties
CUZ
+$121M
4
DLR icon
Digital Realty Trust
DLR
+$103M
5
VICI icon
VICI Properties
VICI
+$96.6M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
1201
Personalis
PSNL
$1.27B
$3K ﹤0.01%
152
+79
+108% +$1.65K
PTGX icon
1202
Protagonist Therapeutics
PTGX
$8.8B
$3K ﹤0.01%
163
+82
+101% +$3.5K
RAPT
1203
DELISTED
RAPT Therapeutics
RAPT
$3K ﹤0.01%
13
+7
+117% +$1.85K
RPTX
1204
DELISTED
Repare Therapeutics
RPTX
$3K ﹤0.01%
127
+58
+84% +$1.87K
SNDX icon
1205
Syndax Pharmaceuticals
SNDX
$1.74B
$3K ﹤0.01%
167
+74
+80% +$1.23K
STOK icon
1206
Stoke Therapeutics
STOK
$1.83B
$3K ﹤0.01%
126
+58
+85% +$1.62K
STRO icon
1207
Sutro Biopharma
STRO
$393M
$3K ﹤0.01%
16
+7
+78% +$1.33K
TX icon
1208
Ternium
TX
$9.68B
$3K ﹤0.01%
70
– –
VNDA icon
1209
Vanda Pharmaceuticals
VNDA
$310M
$3K ﹤0.01%
191
+71
+59% +$1.24K
TVRD
1210
Tvardi Therapeutics
TVRD
$22.9M
$3K ﹤0.01%
5
+2
+67% +$1K
AMTI
1211
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$3K ﹤0.01%
132
+66
+100% +$2.09K
ENDP
1212
DELISTED
Endo International plc
ENDP
$3K ﹤0.01%
800
+367
+85% +$1.3K
ZGNX
1213
DELISTED
Zogenix, Inc.
ZGNX
$3K ﹤0.01%
191
+86
+82% +$1.34K
ALT icon
1214
Altimmune
ALT
$581M
$2K ﹤0.01%
136
+74
+119% +$900
ANAB icon
1215
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
60
– –
ANNX icon
1216
Annexon
ANNX
$814M
$2K ﹤0.01%
131
+59
+82% +$1.2K
COLL icon
1217
Collegium Pharmaceutical
COLL
$1.16B
$2K ﹤0.01%
76
– –
DBC icon
1218
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$2K ﹤0.01%
100
– –
DTIL icon
1219
Precision BioSciences
DTIL
$185M
$2K ﹤0.01%
7
+3
+75% +$1.02K
LKFT
1220
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$2K ﹤0.01%
32
+19
+146% +$1.13K
MCRB icon
1221
Seres Therapeutics
MCRB
$46.5M
$2K ﹤0.01%
16
+7
+78% +$1.37K
MRSN
1222
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
10
+5
+100% +$1.46K
PASG icon
1223
Passage Bio
PASG
$14.7M
$2K ﹤0.01%
9
+5
+125% +$1.19K
PLRX icon
1224
Pliant Therapeutics
PLRX
$66.3M
$2K ﹤0.01%
123
+56
+84% +$1.19K
RYTM icon
1225
Rhythm Pharmaceuticals
RYTM
$7.41B
$2K ﹤0.01%
172
+74
+76% +$1.13K
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.